HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Design, synthesis, and anticonvulsant activity of 1-(pyrid-3-ylsulfonamido)-2-nitroethylenes.

Abstract
The lipophilic 1-cycloalkylamino-1-(pyrid-3-yl-sulfonamido)-2-nitr oethylenes were synthesized as bioisosteres of BM-34, an anticonvulsant sulfonylthiourea. Compound 17 (ip) emerged from the maximal electroshock seizure (MES) test with a 50% effective dose (ED50) of 8.25 mg/kg. Its anticonvulsant profile was similar to that of phenytoin (ED50 = 9.51 mg/kg) and of BM-34 (ED50 = 1.19 mg/kg): active in the MES test and inactive in seizures induced by subcutaneous injection of pentetrazole, strychnine, bicuculline, picrotoxin, or N-methyl-D,L-aspartate. The neurotoxicity of 17 (TD50 = 113.8 mg/kg) was lower than that of phenytoin (TD50 = 65.5 mg/kg) but higher than that of BM-34 (TD50 = 147.2 mg/kg). Crystallographic study revealed that BM-401 (17) was a zwitterionic structure. Its sulfonamido nitroethylene side chain adopted a conformation which placed the two cycloalkyl rings face to face to form a single hydrophobic area.
AuthorsB Masereel, J Wouters, L Pochet, D Lambert
JournalJournal of medicinal chemistry (J Med Chem) Vol. 41 Issue 17 Pg. 3239-44 (Aug 13 1998) ISSN: 0022-2623 [Print] United States
PMID9703469 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticonvulsants
  • Convulsants
  • Neurotoxins
  • BM 34
  • Phenytoin
  • Thiourea
Topics
  • Animals
  • Anticonvulsants (chemical synthesis, chemistry, pharmacology)
  • Convulsants
  • Crystallography, X-Ray
  • Drug Design
  • Electroshock
  • Male
  • Mice
  • Mice, Inbred Strains
  • Models, Molecular
  • Molecular Conformation
  • Molecular Structure
  • Neurotoxins (chemistry, pharmacology)
  • Phenytoin (pharmacology)
  • Seizures (chemically induced, drug therapy)
  • Stereoisomerism
  • Structure-Activity Relationship
  • Thiourea (analogs & derivatives, chemical synthesis, chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: